Wealthspire Advisors (Maryland)’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-4,890
| Closed | -$232K | – | 455 |
|
|
2020
Q1 | $232K | Sell |
4,890
-106
| -2% | -$5.03K | 0.02% | 353 |
|
|
2019
Q4 | $293K | Buy |
4,996
+12
| +0.2% | +$704 | 0.02% | 381 |
|
|
2019
Q3 | $266K | Buy |
4,984
+20
| +0.4% | +$1.07K | 0.02% | 374 |
|
|
2019
Q2 | $248K | Sell |
4,964
-411
| -8% | -$20.5K | 0.02% | 390 |
|
|
2019
Q1 | $281K | Sell |
5,375
-411
| -7% | -$21.5K | 0.02% | 374 |
|
|
2018
Q4 | $276K | Sell |
5,786
-65
| -1% | -$3.1K | 0.02% | 340 |
|
|
2018
Q3 | $294K | Sell |
5,851
-312
| -5% | -$15.7K | 0.02% | 363 |
|
|
2018
Q2 | $311K | Sell |
6,163
-625
| -9% | -$31.5K | 0.03% | 351 |
|
|
2018
Q1 | $332K | Sell |
6,788
-689
| -9% | -$33.7K | 0.03% | 332 |
|
|
2017
Q4 | $331K | Buy |
7,477
+2,762
| +59% | +$122K | 0.03% | 347 |
|
|
2017
Q3 | $239K | Buy |
4,715
+99
| +2% | +$5.02K | 0.03% | 417 |
|
|
2017
Q2 | $249K | Buy |
4,616
+2,688
| +139% | +$145K | 0.03% | 389 |
|
|
2017
Q1 | $102K | Buy |
1,928
+602
| +45% | +$31.8K | 0.01% | 596 |
|
|
2016
Q4 | $64K | Sell |
1,326
-2,776
| -68% | -$134K | 0.01% | 707 |
|
|
2016
Q3 | $221K | Sell |
4,102
-96
| -2% | -$5.17K | 0.03% | 353 |
|
|
2016
Q2 | $227K | Sell |
4,198
-160
| -4% | -$8.65K | 0.04% | 332 |
|
|
2016
Q1 | $221K | Buy |
4,358
+493
| +13% | +$25K | 0.04% | 337 |
|
|
2015
Q4 | $195K | Buy |
+3,865
| New | +$195K | 0.04% | 362 |
|